The Dictatorship
Marty Makary is out as Trump’s Food and Drug Administration head
WASHINGTON (AP) — The head of the Food and Drug Administration, Dr. Marty Macaryis resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activistsvaping lobbyists and other allies of President Donald Trump.
News of Makary’s departure Tuesday came just 13 months after he was confirmed to lead the powerful regulatory agency.
A surgeon and health researcher, Makary came to prominence among Republicans as an outspoken critic of public health measures during the COVID-19 pandemic, when he frequently appeared on Fox News Channel. But he struggled to manage the FDA’s bureaucracy and failed to win the confidence of its staff after mass layoffsleadership upheavals and a series of controversies in which the agency’s scientific principles appeared to be overridden by political interests, including those of Health Secretary Robert F. Kennedy Jr.
“He’s a great doctor, and he was having some difficulty,” Trump told reporters outside the White House. “But he’s going to go on and he’s going to do well.”
President Donald Trump talks with reporters as he departs the White House for travel to Beijing, Tuesday, May 12, 2026, in Washington, to meet with China’s President Xi Jinping. (AP Photo/Jacquelyn Martin)
President Donald Trump talks with reporters as he departs the White House for travel to Beijing, Tuesday, May 12, 2026, in Washington, to meet with China’s President Xi Jinping. (AP Photo/Jacquelyn Martin)
Trump later confirmed in a social media post that Kyle Diamantas, the agency’s chief for foodsis expected to take over as acting commissioner. Diamantas is an attorney with personal ties to Donald Trump Jr.
In that post, the president included what appeared to be a text message from Makary submitting his resignation. In it, he noted: “I announced 50 major FDA reforms. Joe Biden’s FDA had none.” He thanked Trump for the chance to serve.
The FDA commissioner, as the leader of an agency that regulates billions of dollars in consumer goods and medicines, is often required to juggle competing priorities that straddle science and politics.
Makary faced a unique challenge in balancing calls by Trump and other Republicans to cut red tape at the FDA, while also tending to Kennedy’s interest in scrutinizing the safety of vaccinesdrugs and food additives. The decision to get rid of Makary was made by Kennedy, and then the White House signed off on it, according to an administration official who was granted anonymity because they were not authorized to describe internal dynamics.
Virtually all of the FDA’s senior career officials resigned, retired or were forced out in the first year of the second-term Trump administration, leading to a steady stream of leaks and negative stories in the media cataloging low morale, dysfunction and frustration among staff.
Dr. Marty Makary, commissioner of the Food and Drug Administration, center, speaks while National Institutes of Health Director Dr. Jay Bhattacharya, left, and Health and Human Services Secretary Robert F. Kennedy Jr., right, listen in the Oval Office of the White House, Saturday, April 18, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)
Dr. Marty Makary, commissioner of the Food and Drug Administration, center, speaks while National Institutes of Health Director Dr. Jay Bhattacharya, left, and Health and Human Services Secretary Robert F. Kennedy Jr., right, listen in the Oval Office of the White House, Saturday, April 18, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)
AP AUDIO: Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Speaking with reporters, President Trump says he likes Marty Makary.
Makary’s handpicked deputy, Dr. Vinay Prasadwas pushed out of the agency twice in less than a year for running afoul of specialty drugmakers and groups for patients with rare diseases. Makary appeared poised to weather the controversy, despite an ongoing pressure campaign calling on Trump to fire him.
Recent weeks brought fresh criticisms from other interest groups that the White House considers key to Republican chances in November elections.
Anti-abortion groups have accused Makary of slow-walking an internal review of the abortion pill mifepristonewhich has been on the market for 25 years but remains a target for conservative activists. They are seeking to roll back FDA rules that currently allow the pill to be sent through the mail.
“We look forward to a new FDA commissioner who will put an end to the mail-order abortion drug regime,” said Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America.
Vaping executives told Trump that Makary was blocking approval of their products, including new flavored e-cigarettes seen as crucial to the industry’s survival.
Disposable flavored electronic cigarette devices are displayed for sale at a store in Pinecrest, Fla., June 26, 2023. (AP Photo/Rebecca Blackwell, File)
Disposable flavored electronic cigarette devices are displayed for sale at a store in Pinecrest, Fla., June 26, 2023. (AP Photo/Rebecca Blackwell, File)
Last week, the agency abruptly changed course, authorizing the first fruit-flavored e-cigarettes and issuing guidelines that loosened marketing for major manufacturers. But it wasn’t enough to keep Makary in the job.
A permanent replacement for the FDA job will need to be nominated by Trump and confirmed by the Senate.
Faster drug reviews are overshadowed
As a former regular on Fox News, Makary was aggressive about promoting his accomplishments on cable television and podcasts and in online opinion pieces.
A string of initiatives from Makary aimed to speed up or streamline FDA drug reviews, including dropping certain study requirementsincorporating artificial intelligence into drug evaluations and offering expedited reviews to medicines that support “national interests.”
But pharmaceutical executives rely on the predictability and consistency of FDA decisions, even more than speedy reviews. Makary’s efforts on drug reviews were overshadowed by internal conflicts and disputes that created headaches for drugmakers, investors and patients.
More than a half-dozen drugmakers studying therapies for rare or hard-to-treat diseases said they received rejection letters or requests to run additional studies for drugs that had previously been given the go-ahead by FDA staff. Those drugs were primarily overseen by Prasad, who stepped down for a second time from his role as the FDA’s vaccine and biotech chief in April.
The U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md., Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File)
The U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md., Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File)
Vaccine moves denounced
Prasad repeatedly overruled vaccine staffers to restrict eligibility for new coronavirus shots. In February, Prasad initially refused to even consider Moderna’s mRNA shot for flu. The FDA was forced to reverse itself after Moderna pledged to formally challenge the decision and called for intervention by the White House.
Some of Makary and Prasad’s most controversial vaccine proposals never came to fruition, despite stoking confusion and anxiety within the FDA and beyond.
In an internal memo in November, Prasad claimed — without publishing evidence — that the FDA had linked COVID-19 shots to the deaths of 10 children. Prasad used that to justify a planned overhaul of the agency’s approach to approving vaccines.
A dozen former FDA commissioners issued a scathing denunciation of the planwarning it would “undermine the public interest” and decimate vaccine development. The FDA has not released its analysis of the deaths or its plan for the vaccine overhaul.
Martin Makary nominated to serve as Commissioner of Food and Drugs at the Department of Health and Human Services, testifies before the Senate Committee on Health, Education, Labor and Pensions on Capitol Hill, March 6, 2025, in Washington. (AP Photo/Jose Luis Magana, File)
Martin Makary nominated to serve as Commissioner of Food and Drugs at the Department of Health and Human Services, testifies before the Senate Committee on Health, Education, Labor and Pensions on Capitol Hill, March 6, 2025, in Washington. (AP Photo/Jose Luis Magana, File)
FDA’s drug center had a revolving door
In the FDA’s drug center, which is the agency’s largest division, Makary oversaw a revolving door of leadership changes. Six people served as director over the course of one year.
Makary’s initial pick for the job, Dr. George Tidmarsh, was forced to resign after allegations that he used his FDA position to pursue a personal vendetta against a former business partner.
His replacement, longtime FDA cancer specialist Dr. Rick Pazdurannounced he would retire after just three weeks on the job, after clashing with Makary on multiple issues surrounding drug reviews.
With Makary’s departure, the fate of many of his fledgling initiatives is uncertain.
Most of the programs Makary introduced have not gone through federal rulemaking required to enshrine them in U.S. law. Democrats in Congress have questioned the legality of some of those efforts, including a program that offers drugmakers expedited reviews for innovative medicines.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Over the course of June, Donald Trump spent nearly every day focusing attention on assorted construction and beautification projects, emphasizing the unavoidable conclusion that the president takes his renovation crusade very seriously.
His allies aren’t necessarily pleased. The Hill recently reported that Republican officials, worried about the midterm elections and maintaining partisan control, have been “thrown off-balance” by, among other things, Trump’s focus on “pet projects” instead of more meaningful national priorities.
The list of projects keeps growing nevertheless. It includes (but is by no means limited to) the ballroomthe Reflecting Poolthe “triumphal arch,” the fountainsthe horse statuesthe “Trump Promenade,” the “statue garden” and the dozen or so additional renovation projects he’s prioritized in and around the White House complex.
But let’s also not forget the helipad.
A couple of months ago, The Washington PostThe Wall Street Journal and The New York Times separately published similar reports about Trump hoping to build a permanent helicopter landing site on the White House grounds. Evidently, those plans have now advanced to the construction stage. The Post reported this week:
President Donald Trump has begun construction on a new White House helipad, his latest change to the historic grounds, according to three people who spoke on the condition of anonymity because they were not authorized to discuss the project publicly.
Construction crews worked into the night Monday on the White House’s South Lawn, with the project blocked off by a large fence.
The report, which has not been independently verified by MS NOW, added that the project hasn’t yet been formally announced by the White House, even as construction is apparently underway.
It’s not yet clear how much the project will cost, who will pick the tab and whether this has joined the growing list of no-bid contracts.
Unlike some of the president’s other priorities, there is a legitimate issue here — the latest generation of helicopters really do damage the White House lawn — although this doesn’t answer the other lingering questions or explain why Team Trump hasn’t acknowledged the existence of the project.
What’s more, this almost certainly won’t be the last of the Republican’s projects.
Earlier this week, the president used his social media platform to promote an artificial intelligence-generated image of a gold eagle affixed to the White House exterior. Trump added in his online image, “A Golden Gift to the White House for its 250th Birthday Year!”
The text (which erroneously said the White House is celebrating its semiquincentennial) suggested the president intends to add this gaudy addition to his ambitious renovation agenda.
Recent polling has found two-thirds of Americans are convinced their unpopular president simply has the wrong priorities. Trump could take steps to change their mind, but he apparently doesn’t want to.
Steve Benen is a producer for “The Rachel Maddow Show,” the editor of MaddowBlog and an MS NOW political contributor. He’s also the bestselling author of “Ministry of Truth: Democracy, Reality, and the Republicans’ War on the Recent Past.”
The Dictatorship
Hegseth blasts protesters at ceremony for D.C. Safe and Beautiful Task Force: ‘Ingrates’
Defense Secretary Pete Hegseth on Thursday derided protesters at an event in Washington, D.C., tied to the America 250 celebrationscalling the demonstrators “ingrates” who are “blinded by ideology.”
The D.C. Safe and Beautiful Task Force event in Meridian Hill Park was set to begin at 9 a.m. ET but did not start until roughly 30 minutes later, as members of the National Guard waited for Hegseth’s arrival amid a brutal heat wave. Protesters shouted during his brief address, in which he said he was to blame for the delay and praised the troops for their service.
“In fact, this background noise this morning is perfect,” Hegseth said about the protesters, with White House adviser Stephen Miller and acting Attorney General Todd Blanche standing behind him.
“It’s the sound of ingrates, of ingratitude of people who are so blinded by ideology they can’t see law and order and common sense in front of them,” Hegseth said. “That there’s nothing ideological about this group, there’s nothing political about this exercise.”
Some protesters could be heard shouting “Shame!” and “Guard, go home!”
Pete Hegseth: “This background noise is perfect. It’s the sound of ingrates, of ingratitude, of people who are so blinded by ideology they can’t see law and order and common sense in front of them.” pic.twitter.com/aWt5ciuRG3
—Aaron Rupar (@atrupar)”https://x.com/atrupar/status/2072679604184109222?ref_src=twsrc%5Etfw”>July 2, 2026
National Guard troops have been deployed to assist with America 250 celebrations in the capital, though some Democratic governors have warned against their guard members being utilized for a larger federal joint task force to tackle what the Trump administration has called“rampant crime” in Washington.
Many Washington residents are not thrilled with the National Guard’s presence. The controversial America 250 festivities have also sparked criticism from Democrats who accuse President Donald Trump of putting himself at the center of the celebrations.
At the Thursday ceremony, Hegseth suggested the protesters were not from Washington.
“These ingrates will fade away; they’ll go back to wherever they came from,” he said, before asserting that National Guard troops have brought the crime rate down in the capital — a claim that at least one study has found to be inaccurate.
“The crime rate here has dropped in staggering amounts, and the media won’t want to admit it because, of course, they’d have to give credit to President Trump, and then they’d have to give credit to the Department of War or to Stephen Miller,” Hegseth said. “But courageous men like President Trump and Stephen, who said enough is enough, are the reason why this city is a safe and beautiful place.”
Clarissa-Jan Lim is a breaking news reporter for MS NOW. She was previously a senior reporter and editor at BuzzFeed News.
Stephanie Ruhle said she was left “almost speechless” after the release of Donald Trump’s new financial disclosureswhich reported he raked in more than $2 billion since returning to the White House. “Man, it looks good to be president,” the “Money, Power, Politics” host said Wednesday.
According to the 927-page document released Tuesday, Trump’s income has only increased since retaking the White House. The president reported almost $575 million in real estate and golf-related income and another $68.6 million in royalties and licensing fees.
But, as Ruhle pointed out, $1.4 billion of Trump’s 2025 total comes directly from one industry: crypto.
Despite having called that industry a “scam” and a “disaster waiting to happen” in 2021, Trump has in recent years appeared to have a change of heart about digital currency.
“That was just five years ago, but now he is a major crypto industry operator and essentially its top policy maker,” the MS NOW host said. “Remember, he is the one who appointed regulators that changed the rules to hugely benefit the crypto industry, and since he came back to office, he has either completely dropped or settled a whole lot of cases with crypto companies.”
As Trump rakes in more cash, Ruhle said the American people are not experiencing the same kind of prosperity, in part because of the administration’s policies. “[They] are suffering, whether it’s because of tariffs, whether it’s because of inflation, whether it’s because of increased costs, because of the war in Iran,” she said.
While Ruhle noted the president has said he does not choose his investments and has said they are in a “blind account,” she said the American people should not ignore how much Trump has profited since returning to the White House.
“Here’s what you need to know: All of this would be a major conflict of interest — a huge scandal — if it were any other presidency,” she argued.
You can watch Ruhle’s full breakdown in the clip below.
Allison Detzel is an editor/producer for MS NOW. She was previously a segment producer for “AYMAN” and “The Mehdi Hasan Show.”
- Work reportedly begins on White House helipad as part of Trump’s renovation agenda
- Hegseth blasts protesters at ceremony for D.C. Safe and Beautiful Task Force: ‘Ingrates’
- Stephanie Ruhle breaks down what to know about Trump’s financial disclosures
- The stock market is not the litmus test the American public wants
- Despite his recent antics, acting DNI Bill Pulte gets broad declassification powers
- The European sports host with the most
- When a World Cup exit becomes a political crisis
- House Ethics says it doesn’t have information to share on lawmaker sexual misconduct settlements
- AOC endorses El-Sayed in Michigan Senate race
- Capitol agenda: Congress is settling in for a do-nothing summer
-
Politics1 year agoFormer ‘Squad’ members launching ‘Bowman and Bush’ YouTube show
-
The Dictatorship1 year agoLuigi Mangione acknowledges public support in first official statement since arrest
-
Politics1 year agoFormer Kentucky AG Daniel Cameron launches Senate bid
-
The Josh Fourrier Show2 years agoDOOMSDAY: Trump won, now what?
-
Uncategorized2 years ago
Bob Good to step down as Freedom Caucus chair this week
-
The Dictatorship1 year agoPete Hegseth’s tenure at the Pentagon goes from bad to worse
-
Politics1 year agoBlue Light News’s Editorial Director Ryan Hutchins speaks at Blue Light News’s 2025 Governors Summit
-
The Dictatorship10 months agoMike Johnson sums up the GOP’s arrogant position on military occupation with two words